Resultats de la cerca - Francesco Perrone

Refinar resultats
  1. 1
    Real-World Evidence in Oncology: Opportunities and Limitations

    Real-World Evidence in Oncology: Opportunities and Limitations per Massimo Di Maïo, Francesco Perrone, Pierfranco Conté

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    The Effects of Patient-Reported Outcome Screening on the Survival of People with Cancer: A Systematic Review and Meta-Analysis

    The Effects of Patient-Reported Outcome Screening on the Survival of People with Cancer: A Systematic Review and Meta-Analysis per Caterina Caminiti, Giuseppe Maglietta, Francesca Diodati, Matteo Puntoni, Barbara Marcomini, Silvia Lazzarelli, Carmine Pinto, Francesco Perrone

    Publicat 2022
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  3. 3
    Target-based therapies in breast cancer: current status and future perspectives

    Target-based therapies in breast cancer: current status and future perspectives per Nicola Normanno, Alessandro Morabito, Antonella De Luca, Maria Carmela Piccirillo, Marianna Gallo, Monica R. Maiello, Francesco Perrone

    Publicat 2009
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  4. 4
    Individual Patient Data Meta-Analysis of Docetaxel Administered Once Every 3 Weeks Compared With Once Every Week Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer

    Individual Patient Data Meta-Analysis of Docetaxel Administered Once Every 3 Weeks Compared With Once Every Week Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer per Massimo Di Maïo, Francesco Perrone, Paolo Chiodini, Ciro Gallo, Carlos Camps, Wolfgang Schuette, Élisabeth Quoix, Chun-Ming Tsai, Cesare Gridelli

    Publicat 2007
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  5. 5
    Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer

    Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer per Nicola Normanno, Massimo Di Maïo, Ermelinda De Maio, Antonella De Luca, A. De Matteis, Antonio Giordano, Francesco Perrone, NULL AUTHOR_ID

    Publicat 2005
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  6. 6
    Angiogenesis Inhibitors in NSCLC

    Angiogenesis Inhibitors in NSCLC per Anna Manzo, Agnese Montanino, Guido Carillio, Raffaele Costanzo, Claudia Sandomenico, Nicola Normanno, Maria Carmela Piccirillo, Gennaro Daniele, Francesco Perrone, Gaetano Rocco, Alessandro Morabito

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  7. 7
    Press releases of industry-sponsored clinical trials in oncology: characteristics, timing and financial impact

    Press releases of industry-sponsored clinical trials in oncology: characteristics, timing and financial impact per Anna Amela Valsecchi, Cecilia Conte, Nicola Maria Fiore, Maria Lucia Iacovino, Daniele Ierace, Letizia Galeasso, Eleonora Paganoni, Oriana Ciani, Francesco Perrone, Massimo Di Maïo

    Publicat 2025
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Vandetanib (ZD6474), a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor (VEGFR) and Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinases: Current Status and Future Directions

    Vandetanib (ZD6474), a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor (VEGFR) and Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinases: Current Status and Future... per Alessandro Morabito, Maria Carmela Piccirillo, Fabiano Falasconi, Gianfranco De Feo, Antonia Del Giudice, Jane Bryce, Massimo Di Maïo, Ermelinda De Maio, Nicola Normanno, Francesco Perrone

    Publicat 2009
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  9. 9
    Weekly paclitaxel as first-line chemotherapy in elderly advanced breast cancer patients: a phase II study of the Gruppo Italiano di Oncologia Geriatrica (GIOGer)

    Weekly paclitaxel as first-line chemotherapy in elderly advanced breast cancer patients: a phase II study of the Gruppo Italiano di Oncologia Geriatrica (GIOGer) per Lucia Del Mastro, Francesco Perrone, Lazzaro Repetto, Luigi Manzione, Vittorina Zagonel, Lucia Fratino, Daniela Marenco, M. Venturini, Enrico Maggi, Claudia Bighin, T. Catzeddu, Antonella Venturino, R. Rosso

    Publicat 2005
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Meta-Analysis of Single-Agent Chemotherapy Compared With Combination Chemotherapy As Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer

    Meta-Analysis of Single-Agent Chemotherapy Compared With Combination Chemotherapy As Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer per Massimo Di Maïo, Paolo Chiodini, Vassilis Georgoulias, Dora Hatzidaki, Koji Takeda, Floris M Wachters, Vittorio Gebbia, Egbert F. Smit, Alessandro Morabito, Ciro Gallo, Francesco Perrone, Cesare Gridelli

    Publicat 2009
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  11. 11
    Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-Analysis

    Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-B... per Bruno Vincenzi, Massimo Di Maïo, Marianna Silletta, Loretta D’Onofrio, Chiara Spoto, Maria Carmela Piccirillo, Gennaro Daniele, Francesca Comito, Eliana Maci, Giuseppe Bronte, Antonio Russo, Daniele Santini, Francesco Perrone, Giuseppe Tonini

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  12. 12
    Second-Line Treatment of Advanced Non-small Cell Lung Cancer

    Second-Line Treatment of Advanced Non-small Cell Lung Cancer per Cesare Gridelli, Andrea Ardizzoni, Fortunato Ciardiello, Nasser H. Hanna, John V. Heymach, Francesco Perrone, Rafael Rosell, Frances A. Shepherd, Nick Thatcher, Johan Vansteenkiste, Luigi De Petris, Massimo Di Maïo, Filippo de Marinis

    Publicat 2008
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    Carboplatin- or Cisplatin-Based Chemotherapy in First-Line Treatment of Small-Cell Lung Cancer: The COCIS Meta-Analysis of Individual Patient Data

    Carboplatin- or Cisplatin-Based Chemotherapy in First-Line Treatment of Small-Cell Lung Cancer: The COCIS Meta-Analysis of Individual Patient Data per Antônio Rossi, Massimo Di Maïo, Paolo Chiodini, Robin Rudd, Hiroaki Okamoto, Dimosthenis Skarlos, Martin Früh, Wendi Qian, Tomohide Tamura, E. Samantas, Taro Shibata, Francesco Perrone, Ciro Gallo, Cesare Gridelli, Olga Martelli, Siow Ming Lee

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  14. 14
    The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline

    The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline per Massimo Di Maïo, Ethan Basch, Fabrice Denis, Lesley Fallowfield, Patricia A. Ganz, Doris Howell, Christoph Kowalski, Francesco Perrone, Angela M. Stover, Puma Sundaresan, Lorraine Warrington, L. Zhang, Kathi Apostolidis, J. Freeman-Daily, Carla Ripamonti, Daniele Santini

    Publicat 2022
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    Early PET/CT Scan Is More Effective Than RECIST in Predicting Outcome of Patients with Liver Metastases from Colorectal Cancer Treated with Preoperative Chemotherapy Plus Bevacizumab

    Early PET/CT Scan Is More Effective Than RECIST in Predicting Outcome of Patients with Liver Metastases from Colorectal Cancer Treated with Preoperative Chemotherapy Plus Bevacizum... per Secondo Lastoria, Maria Carmela Piccirillo, Corradina Caracò, Guglielmo Nasti, Luigi Aloj, Cecilia Arrichiello, Elisabetta de Lutio di Castelguidone, Fabiana Tatangelo, Alessandro Ottaiano, Rosario Vincenzo Iaffaioli, Francesco Izzo, G. Romano, Pasqualina Giordano, Simona Signoriello, Ciro Gallo, Francesco Perrone

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 study

    A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 study per Cesare Gridelli, Ciro Gallo, Massimo Di Maïo, Emiddio Barletta, Anna Illiano, Paolo Maione, Stefania Salvagni, Franco Vito Piantedosi, Giovanni Palazzolo, Orazio Caffo, A. Ceribelli, Alfredo Falcone, Paola Mazzanti, L Brancaccio, Marco Alex Capuano, L. Isa, Santi Barbera, Francesco Perrone

    Publicat 2004
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Pretreatment Quality of Life and Functional Status Assessment Significantly Predict Survival of Elderly Patients With Advanced Non—Small-Cell Lung Cancer Receiving Chemotherapy: A Prognostic Analysis of the Multicenter Italian Lung Cancer in the Elderly Study

    Pretreatment Quality of Life and Functional Status Assessment Significantly Predict Survival of Elderly Patients With Advanced Non—Small-Cell Lung Cancer Receiving Chemotherapy: A... per Paolo Maione, Francesco Perrone, Ciro Gallo, Luigi Manzione, Francovito Piantedosi, Santi Barbera, S. Cigolari, Francesco Rosetti, Elena Piazza, Sergio Robbiati, Oscar Bertetto, Silvia Novello, Maria Rita Migliorino, Adolfo Favaretto, Mario Spatafora, Francesco Ferraù, Luciano Frontini, Alessandra Bearz, Lazzaro Repetto, Cesare Gridelli

    Publicat 2005
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Single-Agent Gemcitabine As First-Line Treatment of Patients With Advanced Pancreatic Cancer: The GIP-1 Study

    Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Single-Agent Gemcitabine As First-Line Treatment of Patients With Advanced Pancreatic Cancer: The GIP-1 Study per Giuseppe Colucci, Roberto Labianca, Francesco Di Costanzo, Vittorio Gebbia, Giacomo Cartenì, B. Massidda, E. Dapretto, Luigi Manzione, Elena Piazza, Mirella Sannicolò, Marco Ciaparrone, Luigi Cavanna, Francesco Giuliani, Evaristo Maiello, Antonio Testa, Paolo Pederzoli, Massimo Falconi, Ciro Gallo, Massimo Di Maïo, Francesco Perrone

    Publicat 2010
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer

    Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer per Massimo Di Maïo, Cesare Gridelli, Ciro Gallo, Luigi Manzione, L Brancaccio, Santi Barbera, Sergio Robbiati, Giovanni Pietro Ianniello, Francesco Ferraù, E. Piazza, L. Frontini, Francesco Rosetti, Francesco Carrozza, Alessandra Bearz, Mario Spatafora, Vincenzo Adamo, L. Isa, R.V. Iaffaioli, Enrico Di Salvo, Francesco Perrone

    Publicat 2004
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Topotecan Compared With No Therapy After Response to Surgery and Carboplatin/Paclitaxel in Patients With Ovarian Cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) Randomized Study

    Topotecan Compared With No Therapy After Response to Surgery and Carboplatin/Paclitaxel in Patients With Ovarian Cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) Rando... per Sabino De Placido, Giovanni Scambia, Giovanni Di Vagno, Emanuele Naglieri, Alessandra Lombardi, R. Biamonte, Marco Marinaccio, Giacomo Cartenì, Luigi Manzione, Antonio Febbraro, A. De Matteis, Gianpietro Gasparini, Maria Rosaria Valerio, Saverio Danese, Francesco Perrone, Rossella Lauria, Michelino De Laurentiis, Stefano Greggi, Ciro Gallo, Sandro Pignata

    Publicat 2004
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: